Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Weber

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Molecular and Cellular Biology|December 12, 2007
A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and functionAnthony J Apicelli, Leonard B Maggi, Angela C Hirbe, et al.
Plos One|January 7, 2011
The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in miceDaniel A Rauch, Michelle A Hurchla, John C Harding, et al.
Cancer Research Communications|December 18, 2025
Epithelial-Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell LinesAlexander Zheleznyak, Dhanusha Duraiyan, Prasanth Thunuguntla, et al.
Cell|June 11, 2013
Posttranscriptional control of T cell effector function by aerobic glycolysisChih-Hao Chang, Jonathan D Curtis, Leonard B Maggi, et al.
Cancer Research|April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancerRobert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
ADAR1 Regulates Lipid Remodeling through MDM2 to Dictate Ferroptosis SensitivityChe-Pei Kung, Nick D Terzich, Ma Xenia G Ilagen, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Nature Communications|September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancerAlex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Nature Communications|January 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trialTim Kong, Alex Mabry, Maureen Highkin, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Molecular and Cellular Biology|December 12, 2007
A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and functionAnthony J Apicelli, Leonard B Maggi, Angela C Hirbe, et al.
Plos One|January 7, 2011
The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in miceDaniel A Rauch, Michelle A Hurchla, John C Harding, et al.
Cancer Research Communications|December 18, 2025
Epithelial-Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell LinesAlexander Zheleznyak, Dhanusha Duraiyan, Prasanth Thunuguntla, et al.
Cell|June 11, 2013
Posttranscriptional control of T cell effector function by aerobic glycolysisChih-Hao Chang, Jonathan D Curtis, Leonard B Maggi, et al.
Cancer Research|April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancerRobert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
ADAR1 Regulates Lipid Remodeling through MDM2 to Dictate Ferroptosis SensitivityChe-Pei Kung, Nick D Terzich, Ma Xenia G Ilagen, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Nature Communications|September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancerAlex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Nature Communications|January 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trialTim Kong, Alex Mabry, Maureen Highkin, et al.
Pageof 6